MIRM
MirumANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
MIRM vs peer average
79/100
MIRM vs. peer average (A vs. C)
Grade spread
A 2 · B 2 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead is not a size match, but it is relevant as a liver-disease and antiviral benchmark; Mirum’s HDV and cholestatic-liver assets can be framed against a far larger commercial and regulatory execution platform.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MIRM
Mirum
GILD
Gilead Sciences
Grade
A
C
Momentum
72
35
Value
49
64
Sentiment
73
61
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs GILD
MIRM / GILD
Grade Position
Above peers
MIRM vs. peer average (A vs. C)
79/100
Momentum
72
MIRMValue
49
GILDSentiment
73
MIRMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MIRM
GILD is the first peer returned for this comparison set.